Sontidejkul Supistha, Phuengmaung Pornpimol, Saisorn Wilasinee, Kaewduangduen Warerat, Doi Kent, Boonmee Atsadang, Benjaskulluecha Salisa, Palaga Tanapat, Leelahavanichkul Asada
Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Center of Excellence on Translational Research in Inflammation and Immunology (CETRII), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Inflamm Res. 2025 Aug 9;74(1):109. doi: 10.1007/s00011-025-02077-6.
Fibroblast growth factor 21 is a molecule responsible for cell energy regulation, mainly produced from hepatocytes, while O6-methylguanine-DNA methyltransferase is a mandatory enzyme for DNA repair.
Because tumors in the livers might enhance hepatocytic FGF-21 production for supporting tumor-associated macrophages (TAM) to promote cancers, the intrahepatic tumor injection model was performed.
Indeed, intrahepatic injection of MC38 cells in wild-type mice increased FGF-21 in serum and liver tissue. Murine hepatocytes excreted FGF-21 after induction by cell stresses, lipopolysaccharide, and MC38 supernatant, while human hepatocytes (HepG2) produced FGF-21 after incubation with the conditioned media of CaCO, but neither HK2 nor H292. Intrahepatic MC38 injection in mgmt null mice demonstrated a lower tumor size and intratumoral TAM (CD206-positive cells) but higher FGF-21 production when compared with intrahepatic tumors in mgmt control. Additionally, MC38 supernatant induced M2-like polarization, which was enhanced by recombinant FGF-21. Furthermore, TAM induction by MC38 supernatant caused cell stresses only in mgmt null macrophages but not in mgmt control cells, as indicated by increased cell-free DNA and malondialdehyde with reduced maximal respiration. The TAM transformation-induced cell injury was neutralized by recombinant FGF-21.
TAM transformation in mgmt null macrophages induced more severe cell injuries than mgmt control macrophages, leading to the less abundant intratumoral TAM and increased FGF-21 to attenuate the injuries in mgmt null mice with tumors. Further studies on FGF-21 and MGMT in cancers are interesting.
成纤维细胞生长因子21是一种负责细胞能量调节的分子,主要由肝细胞产生,而O6-甲基鸟嘌呤-DNA甲基转移酶是DNA修复的必需酶。
由于肝脏中的肿瘤可能会增强肝细胞FGF-21的产生,以支持肿瘤相关巨噬细胞(TAM)促进癌症,因此进行了肝内肿瘤注射模型实验。
确实,在野生型小鼠中肝内注射MC38细胞会增加血清和肝组织中的FGF-21。小鼠肝细胞在受到细胞应激、脂多糖和MC38上清液诱导后会分泌FGF-21,而人肝细胞(HepG2)在与CaCO的条件培养基孵育后会产生FGF-21,但HK2和H292均不会产生。与mgmt对照小鼠的肝内肿瘤相比,在mgmt基因敲除小鼠中进行肝内MC38注射显示肿瘤大小和瘤内TAM(CD206阳性细胞)较低,但FGF-21产生较高。此外,MC38上清液诱导M2样极化,重组FGF-21可增强这种极化。此外,MC38上清液诱导的TAM会仅在mgmt基因敲除巨噬细胞中引起细胞应激,而在mgmt对照细胞中则不会,这表现为游离DNA和丙二醛增加,最大呼吸降低。重组FGF-21可中和TAM转化诱导的细胞损伤。
mgmt基因敲除巨噬细胞中的TAM转化比mgmt对照巨噬细胞诱导更严重的细胞损伤,导致瘤内TAM数量减少,FGF-21增加,以减轻mgmt基因敲除肿瘤小鼠的损伤。对癌症中FGF-21和MGMT的进一步研究很有意义。